BH3-only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L/TRAIL-induced apoptosis.

Molecular Cancer Therapeutics
J L MottGregory J Gores

Abstract

Human cholangiocarcinomas evade apoptosis by overexpression of Mcl-1. The drug obatoclax (GX15-070) inhibits antiapoptotic members of the Bcl-2 family including Mcl-1. The purpose of this study is to determine if obatoclax sensitizes human cholangiocarcinoma cells to apoptosis. The human cholangiocarcinoma cell lines, KMCH, KMBC, and TFK, were employed for these studies. Protein expression was assessed by immunoblot and protein-protein interactions detected by coprecipitation of the polypeptide of interest with S-tagged Mcl-1. Activation of Bak and Bax was observed by immunocytochemistry with conformation-specific antisera. Obatoclax induced minimal apoptosis alone; however, it increased apoptosis 3- to 13-fold in all three cancer cell lines when combined with Apo2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Obatoclax did not alter cellular expression of Bid, Bim, Puma, Noxa, Bak, Bax, Mcl-1, or cFLIP. Mcl-1 binding to Bak was readily identified in untreated cells, and this association was disrupted by treating the cells with obatoclax. Additionally, Bim binding to Mcl-1 was markedly decreased by obatoclax treatment. We also identified alterations in Bak and Bax conformation following treatment with obatoc...Continue Reading

References

May 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T MurakamiM Kojiro
Sep 1, 1995·The Tohoku Journal of Experimental Medicine·S SaijyoS Matsuno
Oct 28, 1999·The New England Journal of Medicine·P C de GroenD M Nagorney
Jun 8, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T Patel
Jan 10, 2002·Genes & Development·Yibin DengXiangwei Wu
Nov 26, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Young-Soo KimDavid A Brenner
Oct 12, 2004·The International Journal of Biochemistry & Cell Biology·Jorg MichelsGraham Packham
May 20, 2005·Nature·Tilman OltersdorfSaul H Rosenberg
Sep 17, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Norihisa IshimuraGregory J Gores
Oct 26, 2005·Current Opinion in Cell Biology·Simon N Willis, Jerry M Adams
Feb 16, 2006·The Journal of Biological Chemistry·Jie HanHannah Rabinowich
Apr 29, 2006·Cell Death and Differentiation·D ZhaiJ C Reed
Oct 20, 2006·Current Opinion in Cell Biology·Xue Wei MengScott H Kaufmann
Oct 21, 2006·Molecular Cell·Loren D WalenskyStanley J Korsmeyer
Nov 14, 2006·Cancer Cell·Anthony Letai
Nov 23, 2006·Nature Cell Biology·Hyungjin KimEmily H-Y Cheng
Mar 22, 2007·The Journal of Biological Chemistry·Jie HanHannah Rabinowich
Apr 4, 2007·Oncogene·J L MottG J Gores
Apr 28, 2007·The Journal of Biological Chemistry·Shogo KobayashiGregory J Gores
Nov 28, 2007·Proceedings of the National Academy of Sciences of the United States of America·Mai NguyenGordon C Shore

❮ Previous
Next ❯

Citations

Jan 22, 2009·Apoptosis : an International Journal on Programmed Cell Death·Anna FrenzelAndreas Villunger
Aug 7, 2013·Apoptosis : an International Journal on Programmed Cell Death·Octavian BucurRoya Khosravi-Far
Jan 1, 2010·Cell Death & Disease·F McCoyD A Fennell
Feb 18, 2010·Cancer Research·Rory L SmootGregory J Gores
Dec 12, 2012·Cancer Research·Joachim C MertensGregory J Gores
Sep 9, 2011·Genes & Cancer·Rana ElkholiJerry E Chipuk
May 11, 2013·Chemical Biology & Drug Design·Zhichao ZhangShenghui Xie
Aug 11, 2010·Biochemical Pharmacology·Lisa S ChenVarsha Gandhi
Dec 29, 2009·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·J H StegehuisF A E Kruyt
Jan 22, 2010·International Journal of Cancer. Journal International Du Cancer·Benedetto FarsaciJames W Hodge
Jul 23, 2015·Journal of Experimental & Clinical Cancer Research : CR·Martina Broecker-PreussKlaus Mann
Jan 13, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Daisaku YamadaGregory J Gores
Dec 27, 2011·Expert Opinion on Therapeutic Patents·Naval BajwaZaneta Nikolovska-Coleska
Jan 22, 2013·Communicative & Integrative Biology·Qiang Liu, Hong-Gang Wang
Sep 29, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Jung-Chen SuChung-Wai Shiau
Nov 13, 2010·Journal of Cellular and Molecular Medicine·Eva SzegezdiAfshin Samali
Jun 29, 2014·The Journal of Biological Chemistry·Sumera RizviGregory J Gores
Jan 31, 2016·The Journal of Biological Chemistry·Sumera RizviGregory J Gores
Feb 22, 2018·Oncotarget·Sumera RizviGregory J Gores
Feb 15, 2020·Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences·Chisato NaraharaJuntra Karbwang

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis